fda announcement tirzepatide Grants a New Indication for Obesity Management Tirzepatide gains FDA approval for

Secure Checkout Encrypted payment flow and protected order data

With respect to recurrent hospital admissions for HE, the importance of individualized lactulose dose titration stands out, given that 22% of readmissions at 30 days can be prevented.50 16 Lactulose can be recommended as primary prophylaxis in patients with cirrhosis that present with high risk factors for developing episodic overt HE

When to Expect Weight Loss Results Research shows that noticeable weight loss with semaglutide often begins after about 4-8 weeks of use

In this article, we explored what semaglutide is, how it works, and how it might affect ovarian cysts

GLP-1 penetration of the US adult population went from 0.1% in 2021 to 1.5% in 2023